Participate in Clinical Trial Research

Alzheimer's Disease Trials


Goal - The treatment being tested may be able to prevent amyloid-β protein plaques from forming in the brain. This might be able to stop Alzheimer’s Disease before it starts.

Time Commitment - 5-8 year clinical trial. Participants will have regular study site visits (8 in the first year, 4 visits a year thereafter)

Location - Boston University Medical Center

Eligibility - This trial is not looking for people with Alzheimer’s, but rather those with a specific form of a gene that can increase the risk of developing the disease.

Not everyone will have this so you will need to get a cheek swab test before you can be enrolled, to see if you’re eligible for the trial. Additionally, to qualify you must:

  • Be 60-75 years old

  • Have not been diagnosed with any memory impairment

  • Have a study partner (click here for more information about study partners)

Generation Program - Actively Enrolling

Recruitment Coordinator: Nicole Gullotti

Phone: 617-358-5382

Email: ngullott@bu.edu


Brain Imaging in Cognitively Healthy, MCI and AD Subjects - Ongoing- Closed to Enrollment

Recruitment Coordinator: Nicole Gullotti

Phone: 617-358-5382

Email: ngullott@bu.edu

 

Time Commitment  - Multiple in-person visits

Location of Study - Boston University Medical Center, and 28 other locations across the country. See all the locations HERE

Eligibility -  Inquire for full eligibility criteria


The A4 Study - Ongoing- Closed to Enrollment

Recruitment Coordinator: Nicole Gullotti

Phone: 617-358-5382

Email: ngullott@bu.edu

Time Commitment - In person visits every 4 weeks for 3 years

Location - On site at Boston University Medical Center or over 70 centers across the United States, Canada, and Australia.  See all the locations HERE

Eligibility - Women and men 65-85 years old with normal thinking and memory abilities. Study partner able to answer questions about your memory once a year required. 


Goal - The purpose of this study is to evaluate the safety, tolerability, and efficacy of BAN2401 from subjects with Early Alzheimer’s Disease. 

Time Commitment - 18 months

Location - Boston University Medical Center, and 67 other locations across the country. See all the locations HERE

Eligibility - Male and female participants between the ages of 50 and 90. Learn more about specific eligibility requirements at the study website HERE.

BAN2401 Clinical Trial - Closed

Recruitment Coordinator: Nicole Gullotti

Phone: 617-358-5382

Email: ngullott@bu.edu